HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice.

Abstract
The endothelium synthesizes and releases several vasodilator substances, including vasodilator prostaglandins, NO, and EDHF. NO-mediated relaxations are reduced by various risk factors, such as diabetes mellitus and hypercholesterolemia. However, it remains to be elucidated whether EDHF-mediated relaxations also are reduced by those factors and their combination. In this study, we addressed this point in mice. We used small mesenteric arteries from control, diabetic (streptozotocin-induced), apolipoprotein-E-deficient (ApoE-/-), and diabetic ApoE-/- mice. In control mice, endothelium-dependent relaxations to acetylcholine were largely mediated by EDHF. This EDHF-mediated component was slightly reduced in diabetic mice, preserved in ApoE-/- mice, and markedly reduced in diabetic ApoE-/- mice with an increase in NO-mediated component and a negative contribution of indomethacin-sensitive endothelium-derived contracting factor (EDCF). Endothelium-independent relaxations to sodium nitroprusside or NS1619, a direct opener of calcium-activated K channels, were attenuated in ApoE-/- and diabetic ApoE-/- mice. Endothelium-dependent hyperpolarizations were significantly reduced in diabetic mice, preserved in ApoE-/- mice, and again markedly reduced in diabetic ApoE-/- mice. These results indicate that hypercholesterolemia alone minimally affects the EDHF-mediated relaxations, and diabetes mellitus significantly attenuated the responses, whereas their combination markedly attenuates the responses with a compensatory involvement of NO and a negative contribution of EDCF.
AuthorsKeiko Morikawa, Tetsuya Matoba, Hiroshi Kubota, Makoto Hatanaka, Takako Fujiki, Shosuke Takahashi, Akira Takeshita, Hiroaki Shimokawa
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 45 Issue 5 Pg. 485-90 (May 2005) ISSN: 0160-2446 [Print] United States
PMID15821445 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins E
  • Benzimidazoles
  • Biological Factors
  • Blood Glucose
  • Endothelium-Dependent Relaxing Factors
  • Lipids
  • Potassium Channels
  • Vasodilator Agents
  • endothelium-dependent hyperpolarization factor
  • NS 1619
  • Nitroprusside
  • Nitric Oxide
  • Acetylcholine
Topics
  • Acetylcholine (pharmacology)
  • Animals
  • Apolipoproteins E (deficiency)
  • Benzimidazoles (pharmacology)
  • Biological Factors (physiology)
  • Blood Glucose (analysis)
  • Diabetes Mellitus, Experimental (physiopathology)
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular (drug effects, physiology)
  • Endothelium-Dependent Relaxing Factors (pharmacology)
  • Hypercholesterolemia (physiopathology)
  • Lipids (blood)
  • Membrane Potentials (drug effects)
  • Mesenteric Arteries (drug effects, physiology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nitric Oxide (pharmacology)
  • Nitroprusside (pharmacology)
  • Potassium Channels (physiology)
  • Vasodilation (drug effects, physiology)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: